As the tumor stage shortened, both PPL-C and Anti-PD-L1 antibody treatments significantly inhibited tumor growth compared to the animals in the control group (with P < 0.01 and P < 0.001 compared to the negative control, respectively). This evidence concerns the gene CD274 and neoplasm.